BE827804A - Methode et compositions pour la mise en oeuvre pharmaceutique des prostaglandines - Google Patents

Methode et compositions pour la mise en oeuvre pharmaceutique des prostaglandines

Info

Publication number
BE827804A
BE827804A BE155295A BE155295A BE827804A BE 827804 A BE827804 A BE 827804A BE 155295 A BE155295 A BE 155295A BE 155295 A BE155295 A BE 155295A BE 827804 A BE827804 A BE 827804A
Authority
BE
Belgium
Prior art keywords
prostaglandins
compositions
pharmaceutical use
pharmaceutical
Prior art date
Application number
BE155295A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE827804A publication Critical patent/BE827804A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015—Esters of acyclic unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018—Esters of cycloaliphatic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE155295A 1974-04-11 1975-04-10 Methode et compositions pour la mise en oeuvre pharmaceutique des prostaglandines BE827804A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16242/74A GB1484591A (en) 1974-04-11 1974-04-11 Prostaglandin compositions

Publications (1)

Publication Number Publication Date
BE827804A true BE827804A (fr) 1975-10-10

Family

ID=10073769

Family Applications (1)

Application Number Title Priority Date Filing Date
BE155295A BE827804A (fr) 1974-04-11 1975-04-10 Methode et compositions pour la mise en oeuvre pharmaceutique des prostaglandines

Country Status (12)

Country Link
US (1) US3978229A (fr)
AU (1) AU497401B2 (fr)
BE (1) BE827804A (fr)
CA (1) CA1049410A (fr)
DK (1) DK137977B (fr)
FR (1) FR2267091B1 (fr)
GB (1) GB1484591A (fr)
IE (1) IE40977B1 (fr)
LU (1) LU72258A1 (fr)
NL (1) NL7504303A (fr)
SE (1) SE7504150L (fr)
ZA (1) ZA752304B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152524A (en) * 1974-04-02 1979-05-01 American Cyanamid Company Cycloalkyl and cycloalkenyl prostaglandin congeners
GB1494321A (en) * 1974-08-08 1977-12-07 Ici Ltd Prostanoic acid derivatives
DE2524955C3 (de) * 1975-06-05 1981-12-03 Hoechst Ag, 6000 Frankfurt Neue Thienyl-Prostaglandine und Verfahren zu ihrer Herstellung
US4028396A (en) * 1975-07-02 1977-06-07 American Cyanamid Company 16,16-Spirocycloalkyl prostaglandin derivatives
JPS5395958A (en) * 1977-01-31 1978-08-22 Ono Pharmaceut Co Ltd Prostaglandin analogues and process for their preparation
US4123463A (en) * 1978-03-21 1978-10-31 The Upjohn Company 2-Decarboxy-2-alkylketone prostaglandins
US4289785A (en) * 1980-08-06 1981-09-15 The Upjohn Company Method and compositions involving prostaglandins
GB8324004D0 (en) * 1983-09-07 1983-10-12 Erba Farmitalia 16-fluoro-16 17-didehydro prostanoids
US5185374A (en) * 1988-05-11 1993-02-09 K.K. Ueno Seiyaku Oyo Kenkyujo Use of 15-ketoprostaglandin E or F compounds for uterine contraction
GB0112699D0 (en) * 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
CN101948484B (zh) * 2010-09-19 2012-07-11 武汉武药科技有限公司 一种曲伏前列素中间体的制备方法

Also Published As

Publication number Publication date
CA1049410A (fr) 1979-02-27
IE40977B1 (en) 1979-09-26
IE40977L (en) 1975-10-11
LU72258A1 (fr) 1976-03-17
DK154975A (fr) 1975-10-12
AU497401B2 (en) 1978-12-14
AU8003875A (en) 1976-10-14
FR2267091A1 (fr) 1975-11-07
GB1484591A (en) 1977-09-01
DK137977B (da) 1978-06-19
FR2267091B1 (fr) 1981-03-27
NL7504303A (nl) 1975-10-14
SE7504150L (sv) 1975-10-13
US3978229A (en) 1976-08-31
DK137977C (fr) 1978-11-13
ZA752304B (en) 1976-03-31

Similar Documents

Publication Publication Date Title
BE826022A (fr) Capsule pour bouteille
FR2295928A1 (fr) Compositions et procedes pour la production de ciments durcis
IT1028449B (it) Amalgama per odontoiatria e metodo per la preparazione dello stesso
RO68142A (fr) Procede pour la preparation des 4-phenylpyperidines
BE829573A (fr) Nouveaux produits opacifiants pour la radiographie
BE827804A (fr) Methode et compositions pour la mise en oeuvre pharmaceutique des prostaglandines
CH533460A (fr) Procédé pour la mise en émulsion de produits pétroliers, composition pour la mise en oeuvre du procédé, émulsion obtenue, et utilisation de l'émulsion
BE834417A (fr) Procede pour la preparation de gaz reducteur
FR2280437A1 (fr) Nouvelles structures pour la distribution de fluides
RO70894A (fr) Procede pour la preparation des phenylalkylamines
FR2298934A1 (fr) Methode pour cultiv
IT1056281B (it) Apparecchio per la produzione di pezzi colati
RO68881A (fr) Procede pour la preparation des anhydrides alefine-succiniques
BE831234A (fr) Procede de dosage radio-immunologique pour la mise en evidence des anticorps de neisseria gonorrheae
RO66914A (fr) Procede pour la preparation des pyrido-benzodiazepinones
IT1016860B (it) Procedimento ed apparecchio per la colata particolarmente di acciaio
IT1051011B (it) Apparato e metodo per la fabbricazione di tubi per colata
IT1042738B (it) Procedimento e dispositivo per la colata di lingotti d acciato
RO63021A (fr) Procede pour la preparation des 3-fluorcephalosporines
SE430895B (sv) Forfarande for kontinuerlig framstellning av cellulosaglykolat
IT1047960B (it) Procedimento per la colata di lingotti
FR2279207A1 (fr) Installation pour l'irradiation des produits fluides
RO68749A (fr) Procede pour la preparation des 2-amidoimidazoles
BE833324A (fr) Appareil pour la production de bicarbonate de sodium
RO66020A (fr) Procede pour la preparation des 3-pyperazinoisoquinolines